Elementis has entered into an agreement to acquire SummitReheis from an affiliate of One Rock Capital Partners for an enterprise value of US$360 million. SummitReheis will become part of an enlarged personal care business within Elementis.
For the year ended 31 December 2016, SummitReheis is expected to report revenue of US$134 million and underlying EBITDA of approximately US$28 million.
SummitReheis is a high quality, high margin specialty chemicals platform that produces a range of critical active ingredients and materials tailored for use in personal care, pharmaceutical and dental products. SummitReheis’ antiperspirant actives business (more than 60 per cent of its sales) is the global leader in the manufacture and sale of active ingredients for antiperspirants and has long standing relationships with key consumer product companies across the Americas, Europe and Asia
